EuroVacc Foundation
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.eurovacc.org
Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial
Phase 1
Completed
- Conditions
- HIV/AIDS
- Interventions
- Biological: DNA-HIV-PT123 & AIDSVAX B/E
- First Posted Date
- 2018-01-05
- Last Posted Date
- 2019-02-07
- Lead Sponsor
- EuroVacc Foundation
- Target Recruit Count
- 49
- Registration Number
- NCT03391375
- Locations
- 🇺🇬
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), Entebbe, Uganda
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
Phase 1
Completed
- Conditions
- HIV/AIDS
- Interventions
- Biological: DNABiological: AIDSVAX B/E
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- EuroVacc Foundation
- Target Recruit Count
- 72
- Registration Number
- NCT02376582
- Locations
- 🇺🇬
Medical Research Council (MRC) /Uganda Virus Research Institute (UVRI), Masaka, Uganda
🇺🇬Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), Entebbe, Uganda
© Copyright 2025. All Rights Reserved by MedPath